Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study

INTRODUCTION: The aim of this study was to assess the efficacy and safety of switching to teneligliptin from other dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM) inadequately controlled despite treatment with a stable dose of other DPP-4 inhibitors. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hae Jin, Kim, Young Sik, Lee, Chang Beom, Choi, Moon-Gi, Chang, Hyuk-Jae, Kim, Soo Kyoung, Yu, Jae Myung, Kim, Tae Ho, Lee, Ji Hyun, Ahn, Kyu Jeung, Min, Kyung Wan, Kyung, Eun Jung, Kim, Yeo Kyeong, Lee, Kwan Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519978/
https://www.ncbi.nlm.nih.gov/pubmed/34536208
http://dx.doi.org/10.1007/s13300-021-01148-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519978/
https://www.ncbi.nlm.nih.gov/pubmed/34536208
http://dx.doi.org/10.1007/s13300-021-01148-1

Ejemplares similares